Long-term pharmacotherapy of obesity 2000 - A review of efficacy and safety

被引:117
作者
Glazer, G [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Rochester, NY USA
关键词
D O I
10.1001/archinte.161.15.1814
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To clarify the efficacy of antiobesity drugs, this article reviews all long-term (greater than or equal to 36 weeks), placebo-controlled trials of obesity pharmacotherapy published since 1960. Since fears of anorexiant-induced heart valve damage preclude many physicians and patients from even considering antiobesity drugs, this area is also reviewed in-depth. Electronic database and manual bibliography search was used to identify all relevant publications. While existing studies are too few and heterogeneous to warrant meta-analysis, their review does provide evidence highly relevant to the safety and efficacy of available anorexiants. Weight loss attributable to obesity pharmacotherapy (ie, in excess of placebo) in trials lasting 36 to 52 weeks was 8.1% or 7.9 kg for those receiving phentermine resin, 5.0% or 4.3 kg for those receiving sibutramine hydrochloride, 3.4% or 3.4 kg for those receiving orlistat, and -1.5% or -1.5 kg for those receiving diethylpropion hydrochloride. Physiologic, pathologic, and epidemiological studies strongly support that anorexiant-induced valvulopathy is attributable to specific serotonergic properties of the fenfluramines that are not present with available weight loss drugs.
引用
收藏
页码:1814 / 1824
页数:11
相关论文
共 115 条
[71]   COMPARISON OF CONTINUOUS AND INTERMITTENT ANORECTIC THERAPY IN OBESITY [J].
MUNRO, JF ;
MACCUISH, AC ;
WILSON, EM ;
DUNCAN, LJP .
BRITISH MEDICAL JOURNAL, 1968, 1 (5588) :352-&
[72]   FLUOXETINE IN THE TREATMENT OF OBESE TYPE-2 DIABETIC-PATIENTS [J].
OKANE, M ;
WILES, PG ;
WALES, JK .
DIABETIC MEDICINE, 1994, 11 (01) :105-110
[73]   EXERCISE AS AN ADJUNCT TO WEIGHT-LOSS AND MAINTENANCE IN MODERATELY OBESE SUBJECTS [J].
PAVLOU, KN ;
KREY, S ;
STEFFEE, WP .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 49 (05) :1115-1123
[74]   MEDICAL HAZARDS OF OBESITY [J].
PISUNYER, FX .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (07) :655-660
[75]   WHO WOULD HAVE THOUGHT IT - AN OPERATION PROVES TO BE THE MOST EFFECTIVE THERAPY FOR ADULT-ONSET DIABETES-MELLITUS [J].
PORIES, WJ ;
SWANSON, MS ;
MACDONALD, KG ;
LONG, SB ;
MORRIS, PG ;
BROWN, BM ;
BARAKAT, HA ;
DERAMON, RA ;
ISRAEL, G ;
DOLEZAL, JM ;
DOHM, L .
ANNALS OF SURGERY, 1995, 222 (03) :339-352
[76]   OBESITY IN BRITAIN - GLUTTONY OR SLOTH [J].
PRENTICE, AM ;
JEBB, SA .
BRITISH MEDICAL JOURNAL, 1995, 311 (7002) :437-439
[77]   Liver fibrosis in overweight patients [J].
Ratziu, V ;
Giral, P ;
Charlotte, F ;
Bruckert, E ;
Thibault, V ;
Theodorou, I ;
Khalil, L ;
Turpin, G ;
Opolon, P ;
Poynard, T .
GASTROENTEROLOGY, 2000, 118 (06) :1117-+
[78]  
RAVUSSIN E, 1992, AM J CLIN NUTR, V55, P242
[79]   Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology [J].
Reeve, HL ;
Nelson, DP ;
Archer, SL ;
Weir, EK .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (02) :L213-L219
[80]  
REID CL, 1994, CIRCULATION, V90, P282